Waters (WAT) return on equity (ROE)

Return on equity · fiscal 2025
25.1%

Waters (WAT) earned a return on equity of 25.1% in fiscal 2025 (the year ended December 31, 2025). That is 9.8 percentage points lower than the 34.9% of fiscal 2024. Figures as of 17 Nov 2026, 20:46 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on equity, fiscal 2025
25.1%
Change on fiscal 2024
−9.8 pts
Highest on record
224.7%fiscal 2020
Lowest on record
0.9%fiscal 2017
Fiscal years on record
122007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Waters return on equity (ROE), in more detail

Across the 12 fiscal years on record (2007–2025), the highest was 224.7% in fiscal 2020 and the lowest 0.9% in fiscal 2017. The fiscal 2025 figure is higher than in 18% of the 11 earlier fiscal years on record, whose median is 45.7%.

History · 12 fiscal years

Return on equity by fiscal year

Waters return on equity (ROE), year by year

Waters (WAT) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
202525.1% 9.8 pts down
202434.9% 20.9 pts down
202355.8% 84.5 pts down
2022140.3% 48.2 pts down
2021188.5% 36.2 pts down
2020224.7%—
201837.9% 37.0 pts up
20170.9% 21.7 pts down
201622.7%—
200938.1% 10.7 pts down
200848.8% 3.0 pts up
200745.7%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

Return on equity at health care companies of similar size

Return on equity of Waters and comparable companies
CompanyReturn on equityFiscal year
Teva Pharmaceutical Industries TEVA17.8%2025
BeOne Medicines ONC6.6%2025
Waters WAT25.1%2025
Natera NTRA-12.2%2025
IQVIA Holdings IQV20.9%2025
Revolution Medicines RVMD-69.3%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on WAT

Waters, figure by figure

Waters (WAT) overview: price, valuation and scorecardAll health care companies by market value

Waters return on equity (ROE): questions and answers

What is Waters's return on equity?

Waters (WAT) earned a return on equity of 25.1% in fiscal 2025 (the year ended December 31, 2025). That is 9.8 percentage points lower than the 34.9% of fiscal 2024.

Is Waters's return on equity high or low compared with its own history?

The fiscal 2025 figure is higher than in 18% of the 11 earlier fiscal years on record, whose median is 45.7%.

What are the highest and lowest return on equity figures on record for Waters?

Across the 12 fiscal years on record (2007–2025), the highest was 224.7% in fiscal 2020 and the lowest 0.9% in fiscal 2017.

How is Waters's return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Waters (WAT) return on equity (ROE)”, data as of 17 November 2026. https://funkfolio.com/stock/WAT/roe

Underlying data: the company's filings with the SEC and Yahoo Finance.